Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.

Amin, Alpesh; Bruno, Amanda; Trocio, Jeffrey; Lin, Jay; Lingohr-Smith, Melissa

Amin, Alpesh; Bruno, Amanda; Trocio, Jeffrey; Lin, Jay; Lingohr-Smith, Melissa.

Affiliation

Amin A; University of California , Irvine, CA , USA.

J Med Econ ; 18(6): 399-409, 2015 Jun.

Article in En | MEDLINE | ID: mdl-25586203

Subject(s)

Anticoagulants/economics; Anticoagulants/therapeutic use; Atrial Fibrillation/drug therapy; Venous Thromboembolism/drug therapy; Warfarin/economics; Warfarin/therapeutic use; Cost-Benefit Analysis; Costs and Cost Analysis; Dabigatran/economics; Dabigatran/therapeutic use; Health Expenditures; Hemorrhage/economics; Humans; Models, Econometric; Myocardial Infarction/economics; Pulmonary Embolism/economics; Pyrazoles/economics; Pyrazoles/therapeutic use; Pyridines/economics; Pyridines/therapeutic use; Pyridones/economics; Pyridones/therapeutic use; Rivaroxaban/economics; Rivaroxaban/therapeutic use; Stroke/economics; Thiazoles/economics; Thiazoles/therapeutic use; United States/epidemiology

Key words

Economic model; Healthcare costs; New oral anticoagulants; Non-valvular atrial fibrillation; Venous thromboembolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Warfarin / Venous Thromboembolism / Anticoagulants Type of study: Clinical_trials / Health_economic_evaluation Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Med Econ Journal subject: SERVICOS DE SAUDE Year: 2015 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google